Filing Details
- Accession Number:
- 0000885590-10-000062
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-01 17:49:52
- Reporting Period:
- 2010-11-15
- Filing Date:
- 2010-12-01
- Accepted Time:
- 2010-12-01 17:49:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885590 | Valeant Pharmaceuticals International Inc. | VRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1479927 | Michel Chouinard | C/O 7150 Mississauga Road Mississauga A6 L5N 8M5 | Coo, Biovail Labs.intl Srl | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares, No Par Value | Disposition | 2010-11-15 | 102,600 | $25.16 | 2,528 | No | 4 | S | Direct | |
Common Shares, No Par Value | Disposition | 2010-11-15 | 58 | $25.13 | 2,470 | No | 4 | S | Direct | |
Common Shares, No Par Value | Acquisiton | 2010-11-29 | 32,250 | $22.05 | 34,720 | No | 4 | M | Direct | |
Common Shares, No Par Value | Disposition | 2010-11-29 | 32,250 | $25.30 | 2,470 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares, No Par Value | Stock Options (right to purchase) | Disposition | 2010-11-29 | 32,250 | $0.00 | 32,250 | $22.05 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2010-03-01 | 2012-03-22 | No | 4 | M | Direct |
Footnotes
- Converted from Cdn. $25.33 using the Bank of Canada exchange rate of $0.9935 (exchange rate on the transaction date)
- Converted from Cdn. $25.30 using the Bank of Canada exchange rate of $0.9935 (exchange rate on the transaction date).